HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Israel Fernández-Cadenas Selected Research

Glycogen Storage Disease Type V (McArdle's Disease)

12/2006Novel mutation in the PYGM gene resulting in McArdle disease.
9/2003Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Israel Fernández-Cadenas Research Topics

Disease

24Stroke (Strokes)
10/2022 - 12/2003
15Ischemic Stroke
01/2022 - 07/2005
3CADASIL
07/2021 - 09/2017
2Hemorrhagic Stroke
08/2012 - 06/2006
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2009 - 07/2005
2Brain Ischemia (Cerebral Ischemia)
11/2009 - 06/2006
2Glycogen Storage Disease Type V (McArdle's Disease)
12/2006 - 09/2003
2Brain Injuries (Brain Injury)
06/2006 - 07/2005
1Hematoma
07/2021
1Inflammation (Inflammations)
07/2021
1COVID-19
03/2021
1Hypersensitivity (Allergy)
01/2020
1Atherosclerosis
01/2018
1Cerebral Hemorrhage
03/2016
1Thrombophilia
01/2016
1Hemorrhage
02/2015
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
05/2013
1Muscular Diseases (Myopathy)
05/2013
1Muscular Dystrophies (Muscular Dystrophy)
05/2013
1Embolic Stroke
08/2010
1Gliosis
07/2009
1Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2008
1Transient Ischemic Attack
05/2008
1Infarction (Infarctions)
06/2006

Drug/Important Bio-Agent (IBA)

13Tissue Plasminogen Activator (Alteplase)FDA Link
11/2021 - 12/2003
6Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2010
6Proteins (Proteins, Gene)FDA Link
07/2021 - 07/2005
5Biological ProductsIBA
06/2022 - 08/2017
4Matrix Metalloproteinases (MMPs)IBA
07/2021 - 07/2005
3Pharmaceutical PreparationsIBA
06/2022 - 07/2021
3Fibrinogen (Factor I)FDA Link
01/2016 - 05/2006
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2008 - 12/2003
2Amyloid (Amyloid Fibrils)IBA
07/2021 - 07/2009
2Epidermal Growth Factor (EGF)IBA
07/2021 - 01/2021
2NucleotidesIBA
01/2021 - 05/2013
2fibrin fragment D (D-dimer)IBA
08/2012 - 08/2010
25-Lipoxygenase-Activating ProteinsIBA
03/2012 - 01/2010
1Unithiol (DMPS)IBA
10/2022
1ProteomeIBA
03/2022
1DabigatranFDA Link
01/2022
1tau Proteins (tau Protein)IBA
07/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2021
1Genetic Markers (Genetic Marker)IBA
03/2021
1ThrombomodulinIBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1antithrombin III-protease complexIBA
01/2021
1Prothrombin (Factor II)IBA
01/2021
1VitaminsIBA
01/2021
1Deoxyribonuclease I (Nickase)IBA
01/2020
1Cysteine (L-Cysteine)FDA Link
09/2017
1GuanineIBA
08/2017
1CytosineIBA
08/2017
1Phosphates (Orthophosphate)IBA
08/2017
1Terminator Codon (Termination Codon)IBA
05/2013
1Karyopherins (Importin)IBA
05/2013
1SecretagoginsIBA
08/2012
1cerebellinIBA
08/2012
1Caspase 3 (Caspase-3)IBA
08/2012
1RNA (Ribonucleic Acid)IBA
05/2012
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2010
1CytokinesIBA
11/2009
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2009
1AnticoagulantsIBA
01/2009
1Serine Proteases (Serine Protease)IBA
01/2009
1Protein CIBA
01/2009
1Plasminogen Activators (Plasminogen Activator)IBA
05/2008
1E-SelectinIBA
05/2008
1Lipoprotein(a)IBA
05/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2008
1C-Reactive ProteinIBA
05/2008
1Factor XIII (Coagulation Factor XIII)IBA
09/2006
1FibrinIBA
09/2006
1GelatinIBA
06/2006
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2006
1Plasminogen Activator Inhibitor 1IBA
05/2006
1Metalloproteases (Metalloproteinases)IBA
07/2005
1Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA
09/2003
1Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
09/2003

Therapy/Procedure

6Thrombolytic Therapy
01/2021 - 07/2005
5Therapeutics
07/2021 - 07/2008
2Secondary Prevention
01/2020 - 08/2010
1Activities of Daily Living (ADL)
12/2006